相关实验视频
Updated: Jun 8, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.7K
在宫癌中,CCL22/CCR4的激活导致EMT过程在EZH2-介导的表观遗传调节下重塑
Li Zhang1, Sijuan Tian1, Jie Chang1
1Department of Gynecology and Obstetrics, the First Affiliated Hospital of Xi'an Jiaotong University, No.277 West Yanta Road, Xi'an 710061, China.
Journal of Cancer
|November 8, 2024
概括
增强体同类2 (EZH2) 的增强剂通过DNA甲基转移酶3A (DNMT3A) 通过表观基因激活化基因 (C-C动机) 连接体22 (CCL22) 和其受体 (CCR4),促进宫癌的进展和上皮细胞转化为介质细胞转化 (EMT).
科学领域:
- 表观遗传学和癌症生物学
- 分子瘤学分子瘤学
- 宫癌的发病原因 宫癌的发病原因
背景情况:
- 宫癌 (CC) 在全球范围内对女性构成重大公共卫生挑战.
- 影响基因表达的表观遗传修饰与CC发展有关.
- 化学因子 (C-C动机) 配体22 (CCL22) 和它的受体CC-化学因子受体4 (CCR4) 与瘤进展和转移有关.
研究的目的:
- 为了研究增强肠胃同源2 (EZH2) 在宫癌中CCL22/CCR4表达的表观遗传调节中的作用.
- 阐明EZH2在CC中影响表皮细胞转移到介质细胞转换 (EMT) 的机制.
- 确定DNA甲基转移酶3A (DNMT3A) 在EZH2介导的CCL22/CCR4调节中的参与.
主要方法:
- 对CCL22和CCR4表达和促进体DNA甲基化在CC组织与正常宫组织中的分析.
- 在体外和体内测试以评估DNMT3A与CCL22和CCR4促进体区域的结合.
- 在CC细胞系中抑制EZH2和DNMT3A,以评估它们对基因表达,甲基化和细胞迁移的影响.
- 抑制CCL22蛋白质以评估其对细胞迁移和EMT标记物的影响.
主要成果:
- 在CC组织中,CCL22和CCR4被显著上调,促进体DNA甲基化增加.
- 脱甲基化重新激活了CCL22和CCR4转录,而EZH2下调导致促进体甲基化增加,并通过DNMT3A减少了CCL22/CCR4的mRNA表达.
- EZH2和DNMT3A静止受差异影响的细胞迁移和EMT标记物 (vimentin,slug,牛,β-catenin,ZO-1),与CCL22抑制减少迁移和EMT.
结论:
- EZH2通过DNMT3A在表观遗传上激活CCL22/CCR4表达,有助于EMT和宫癌的进展.
- 针对EZH2/DNMT3A/CCL22/CCR4轴可能为宫癌提供治疗策略.
相关概念视频
Cadherins in Tissue Organization
2.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
Cell Sorting During Development
Cell sorting plays an...
2.9K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Epigenetic Regulation
30.9K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
30.9K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K

